Surgery for Obesity and Related Diseases is an esteemed scholarly journal published by ELSEVIER SCIENCE INC, focusing on cutting-edge research and advancements in the field of obesity surgery. With an impressive impact factor and ranking in the 94th percentile among its peers in Medicine and Surgery, this journal maintains a prestigious position in the Q1 category of surgical studies. Since its inception in 2005, it has served as a vital platform for disseminating original research, clinical studies, and reviews that aim to improve patient outcomes and deepen our understanding of obesity-related diseases. The journal facilitates a wide array of access options, ensuring that professionals, researchers, and students across the globe can engage with current findings and best practices in surgical and medical treatment of obesity. As we look toward 2024 and beyond, Surgery for Obesity and Related Diseases remains committed to fostering innovation in surgical techniques and interdisciplinary approaches to solving one of the most pressing health challenges of our time.

Diabetes Metabolic Syndrome and Obesity is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing research in the fields of diabetes, metabolic syndrome, and obesity. Since its inception in 2008, the journal has aimed to disseminate high-quality, peer-reviewed articles that contribute to our understanding of these prevalent health issues, with a special focus on clinical practices, therapeutic advancements, and epidemiological studies. Boasting a commendable Q2 ranking in both Internal Medicine and Pharmacology for 2023, the journal is placed among the top tier of its category, with a Scopus ranking of #44 out of 167 in Internal Medicine and #124 out of 313 in Pharmacology. This positions the journal in the 73rd and 60th percentiles, respectively, highlighting its significance in the academic community. Researchers and professionals are encouraged to utilize this journal as a valuable resource for access to groundbreaking studies and developments in the treatment and management of diabetes and related metabolic disorders, contributing to global health improvements.

Eating Behaviors is a prestigious peer-reviewed journal published by Elsevier, focusing on the interdisciplinary fields of clinical psychology and psychiatry. With an ISSN of 1471-0153 and E-ISSN 1873-7358, this journal serves as a significant platform for researchers, practitioners, and students interested in the psychological and behavioral aspects of eating. It has achieved recognition in the academic community, boasting a 2023 Scopus ranking that places it in the 68th percentile for Clinical Psychology and the 58th percentile for Psychiatry and Mental Health, affirming its impact in these critical domains. Operating in the United Kingdom, Eating Behaviors has established a reputation for publishing innovative research since its inception in 2000, with a convergence period extending to 2024. The journal aims to illuminate the intricate connections between eating patterns and mental health, making it an essential resource for those investigating the behavioral and psychological factors influencing food choices and disorders. While it does not currently offer open access options, the journal remains committed to advancing the scientific dialogue within this crucial area of health and psychology.

INTERNATIONAL JOURNAL OF OBESITY, published by SpringerNature, stands as a premier multidisciplinary platform for research in the fields of Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, as well as Miscellaneous Medicine. With a remarkable impact, the journal is consistently positioned in the Q1 category across these critical areas, underscoring its significance in advancing the understanding of obesity and its related health outcomes. Established in 1977 and covering a broad spectrum of studies until 2024, it boasts a notable Scopus Rank reflecting its influential contributions to the scientific community, including a rank of 14 out of 140 in Nutrition and Dietetics. The INTERNATIONAL JOURNAL OF OBESITY is not just a repository of knowledge but a vital resource for researchers, clinicians, and students aiming to explore the complexities of obesity and develop evidence-based interventions. Despite not being an open-access journal, its rigorous peer-reviewed articles remain accessible to those within academic institutions, facilitating an essential dialogue among professionals dedicated to this critical global health issue.

Obesity Facts is a prestigious open access journal dedicated to advancing research and insights in the field of obesity, promoting a multidisciplinary approach to understanding its implications across social sciences and medical physiology. Published by KARGER since 2008, this journal has established itself as a crucial resource for researchers and practitioners, achieving a commendable impact factor reflective of its high-quality contributions. As of 2023, it holds a Q1 ranking in Health (social science) and a Q2 ranking in Physiology (medical), further underscoring its significance and influence in the academic community, with notable Scopus rankings of #37 in Health and #29 in Medicine. With an open access model since 2013, Obesity Facts ensures that groundbreaking research is readily available to the global scientific community and contributes to public health discourse, engaging a diverse audience of researchers, health professionals, and students keen on understanding obesity's complex phenomena.

Diabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Nutrition & Metabolism, published by BMC, is a leading open-access journal that has been pivotal in advancing research within the domains of nutrition, metabolic science, and endocrinology since its inception in 2004. With an impressive impact in its field, this journal boasts classification in the Q1 category in both Nutrition and Dietetics and Medicine (miscellaneous), as well as Q2 in Endocrinology, Diabetes and Metabolism for 2023. It ranks in the top percentiles of its Scopus categories, highlighting its significance to the scholarly community, with notable placements such as rank 22 out of 140 in Nutrition and Dietetics. The journal's commitment to open access ensures that groundbreaking research is readily available to researchers, practitioners, and students alike, fostering collaboration and innovation across disciplines. Based in the United Kingdom, Nutrition & Metabolism continues to shape the future of nutritional science and metabolic studies, inviting submissions that address pivotal questions and drive the field forward.

Childhood Obesity is a leading peer-reviewed academic journal published by Mary Ann Liebert, Inc., dedicated to the critical examination of obesity issues affecting children and adolescents. Covering a range of interdisciplinary research within Endocrinology, Diabetes, and Metabolism, Nutrition and Dietetics, and Pediatrics, the journal holds prestigious rankings across multiple categories, including Q1 in Pediatrics, Perinatology, and Child Health, showcasing its impact and quality in the field. With its focus on innovative research and practical solutions, Childhood Obesity invites contributions that advance understanding and strategies for combating childhood obesity, making it an invaluable resource for researchers, healthcare professionals, and students alike. Published from 2010 to 2024, the journal remains committed to enhancing public health knowledge and practices through high-quality, evidence-based studies.

Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.